Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-23

Clinical Trial Update: Evaluation of the Hepatoprotective Effects of a Nutritional Supplement in Patients With Liver Disease Secondary to Chronic Hepatitis C Virus Infection (RESQUETI Study). [NA]

View source ↗

Summary

This clinical trial evaluates the hepatoprotective effects of a nutritional supplement in patients with liver disease caused by chronic hepatitis C infection. T…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nutritional Supplement

Snippet

Sponsor: University of Guadalajara | Conditions: Liver Disease Chronic, HEPATITIS C VIRUS CHRONIC INFECTION | NA | Status: RECRUITING